In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Ginkgo Bioworks Holdings Inc’s stock clocked out at $12.19, down -7.23% from its previous closing price of $13.14. In other words, the price has decreased by -$7.23 from its previous closing price. On the day, 1.35 million shares were traded. DNA stock price reached its highest trading level at $12.55 during the session, while it also had its lowest trading level at $11.7503.
Ratios:
To gain a deeper understanding of DNA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.88 and its Current Ratio is at 4.88. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.67.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 17 ’25 when Coen Steven P. sold 1,084 shares for $9.84 per share. The transaction valued at 10,669 led to the insider holds 10,679 shares of the business.
Dmytruk Mark E. bought 640 shares of DNA for $6,299 on Jul 17 ’25. On Jul 09 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 2,200 shares for $11.18 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 713503808 and an Enterprise Value of 631142592. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.01 while its Price-to-Book (P/B) ratio in mrq is 0.97. Its current Enterprise Value per Revenue stands at 2.658 whereas that against EBITDA is -1.941.
Stock Price History:
The Beta on a monthly basis for DNA is 1.51, which has changed by 0.0024671555 over the last 52 weeks, in comparison to a change of 0.20277917 over the same period for the S&P500. Over the past 52 weeks, DNA has reached a high of $16.85, while it has fallen to a 52-week low of $5.00. The 50-Day Moving Average of the stock is 22.91%, while the 200-Day Moving Average is calculated to be 32.36%.
Shares Statistics:
It appears that DNA traded 1.42M shares on average per day over the past three months and 2040700 shares per day over the past ten days. A total of 43.08M shares are outstanding, with a floating share count of 39.91M. Insiders hold about 31.29% of the company’s shares, while institutions hold 57.35% stake in the company. Shares short for DNA as of 1752537600 were 10340727 with a Short Ratio of 7.31, compared to 1749772800 on 11312529. Therefore, it implies a Short% of Shares Outstanding of 10340727 and a Short% of Float of 22.91.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
